Login / Signup
Superiority of low-dose benzbromarone to low-dose febuxostat in gout patients with renal uric acid underexcretion: Comment on Yan et al.
Tomoyuki Kawada
Published in:
Arthritis & rheumatology (Hoboken, N.J.) (2023)
Keyphrases
</>
uric acid
low dose
metabolic syndrome
high dose